Literature DB >> 15448082

Hypothalamic ATP-sensitive K + channels play a key role in sensing hypoglycemia and triggering counterregulatory epinephrine and glucagon responses.

Mark L Evans1, Rory J McCrimmon, Daniel E Flanagan, Tara Keshavarz, Xiaoning Fan, Ewan C McNay, Ralph J Jacob, Robert S Sherwin.   

Abstract

It has been postulated that specialized glucose-sensing neurons in the ventromedial hypothalamus (VMH) are able to detect falling blood glucose and trigger the release of counterregulatory hormones during hypoglycemia. The molecular mechanisms used by glucose-sensing neurons are uncertain but may involve cell surface ATP-sensitive K(+) channels (K(ATP) channels) analogous to those of the pancreatic beta-cell. We examined whether the delivery of sulfonylureas directly into the brain to close K(ATP) channels would modulate counterregulatory hormone responses to either brain glucopenia (using intracerebroventricular 5-thioglucose) or systemic hypoglycemia in awake chronically catheterized rats. The closure of brain K(ATP) channels by global intracerebroventricular perfusion of sulfonylurea (120 ng/min glibenclamide or 2.7 microg/min tolbutamide) suppressed counterregulatory (epinephrine and glucagon) responses to brain glucopenia and/or systemic hypoglycemia (2.8 mmol/l glucose clamp). Local VMH microinjection of a small dose of glibenclamide (0.1% of the intracerebroventricular dose) also suppressed hormonal responses to systemic hypoglycemia. We conclude that hypothalamic K(ATP) channel activity plays an important role in modulating the hormonal counterregulatory responses triggered by decreases in blood glucose. Our data suggest that closing of K(ATP) channels in the VMH (much like the beta-cell) impairs defense mechanisms against glucose deprivation and therefore could contribute to defects in glucose counterregulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15448082     DOI: 10.2337/diabetes.53.10.2542

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  54 in total

1.  Regulation of glucagon secretion by glucose transporter type 2 (glut2) and astrocyte-dependent glucose sensors.

Authors:  Nell Marty; Michel Dallaporta; Marc Foretz; Martine Emery; David Tarussio; Isabelle Bady; Christophe Binnert; Friedrich Beermann; Bernard Thorens
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 2.  Hyperinsulinaemic hypoglycaemia: biochemical basis and the importance of maintaining normoglycaemia during management.

Authors:  Khalid Hussain; Oliver Blankenstein; Pascale De Lonlay; Henrik T Christesen
Journal:  Arch Dis Child       Date:  2007-07       Impact factor: 3.791

Review 3.  Minireview: The value of looking backward: the essential role of the hindbrain in counterregulatory responses to glucose deficit.

Authors:  Sue Ritter; Ai-Jun Li; Qing Wang; Thu T Dinh
Journal:  Endocrinology       Date:  2011-08-30       Impact factor: 4.736

Review 4.  Role of the hypothalamus in mediating protective effects of dietary restriction during aging.

Authors:  Penny A Dacks; Cesar L Moreno; Esther S Kim; Bridget K Marcellino; Charles V Mobbs
Journal:  Front Neuroendocrinol       Date:  2012-12-20       Impact factor: 8.606

5.  Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.

Authors:  Eva M Fekete; Koki Inoue; Yu Zhao; Jean E Rivier; Wylie W Vale; Attila Szücs; George F Koob; Eric P Zorrilla
Journal:  Neuropsychopharmacology       Date:  2006-10-04       Impact factor: 7.853

6.  Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene.

Authors:  A S Slingerland; R Nuboer; M Hadders-Algra; A T Hattersley; G J Bruining
Journal:  Diabetologia       Date:  2006-09-19       Impact factor: 10.122

7.  Counterregulatory responses to hypoglycemia differ between glimepiride and glyburide in non diabetic individuals.

Authors:  Nino G Joy; Donna B Tate; Stephen N Davis
Journal:  Metabolism       Date:  2015-02-26       Impact factor: 8.694

8.  Glucose sensing during hypoglycemia: lessons from the lab.

Authors:  Rory McCrimmon
Journal:  Diabetes Care       Date:  2009-08       Impact factor: 17.152

9.  Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetes.

Authors:  X Fan; Y Ding; S Brown; L Zhou; M Shaw; M C Vella; H Cheng; E C McNay; R S Sherwin; R J McCrimmon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-04-08       Impact factor: 3.619

10.  Insulin signaling in alpha cells modulates glucagon secretion in vivo.

Authors:  Dan Kawamori; Amarnath J Kurpad; Jiang Hu; Chong Wee Liew; Judy L Shih; Eric L Ford; Pedro L Herrera; Kenneth S Polonsky; Owen P McGuinness; Rohit N Kulkarni
Journal:  Cell Metab       Date:  2009-04       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.